Hims & Hers Q3 revenue $144.8M (+95% YoY); raises FY 2022 guidance; expects Q4 Adj. EBITDA profitability
Hims & Hers Health, Inc.
- Revenue of $144.8M, up 95% YoY; net loss $(18.8)M vs $(15.9)M a year ago.
- Adjusted EBITDA improved to $(6.1)M from $(9.8)M; expects Q4 2022 Adjusted EBITDA profitability.
- Subscriptions reached 991,000 (+80% YoY); Q3 net new subscriptions all-time high >170,000.
- Raises FY 2022 revenue guidance to $519-522M; Adjusted EBITDA guidance to $(20)-$(18)M.
- Gross margin expanded to 79% from 74% YoY; net loss improved on adjusted basis.